Clinical Trials Logo

Opioid Use clinical trials

View clinical trials related to Opioid Use.

Filter by:

NCT ID: NCT03763734 Completed - Chronic Pain Clinical Trials

High-Dose Steroid for Knee Arthroplasty Patients Expected to Have Postoperative Pain

Start date: January 29, 2019
Phase: Phase 4
Study type: Interventional

The purpose of the Study is to test a higher dose of steroids(Dexamethasone) given just prior to surgery in the setting of Fast-Track Knee surgery with Arthroplasty in a group of expected High Pain Responders and the effect on postoperative pain and postoperative inflammation.

NCT ID: NCT03749811 Recruiting - Opioid Use Clinical Trials

Pupillometry-guided Remifentanil Infusion Versus Conventional Administration in Children

PURFT
Start date: December 4, 2018
Phase: N/A
Study type: Interventional

Our study aims to compare the total intravenous dose of remifentanil per anesthesia hour and body weight in two groups of pediatric surgical patients - an interventional group with remifentanil infusion under pupillometry monitoring, and control group without pupillometry - to figure out whether pupillometry monitoring may reduce remifentanil consumption during anesthesia while providing sufficient analgesia for surgical noxious stimuli.

NCT ID: NCT03749564 Terminated - Low Back Pain Clinical Trials

Influence of Opioid Use on the Effects of Spinal Manipulative Therapy for Low Back Pain

Start date: January 17, 2019
Phase: N/A
Study type: Interventional

This project is a supplement to the parent project (UH3AT009293) entitled "Optimization of Spinal Manipulative Therapy (SMT) Protocols". The goal of the parent project is to examine strategies to optimize SMT treatment protocols for patients with low back pain (LBP). The parent project is investigating mechanistic and clinical outcomes of SMT combined with varying co-interventions. This supplemental project will examine the impact of opioid use on these outcomes.

NCT ID: NCT03747341 Completed - Healthy Clinical Trials

Buprenorphine-Fentanyl Interaction Study

Start date: March 22, 2018
Phase: Phase 1
Study type: Interventional

An increase in overdose deaths has been attributed to widespread access to fentanyl and carfentanyl. The study is designed to determine if buprenorphine can change the respiratory depression response to intravenous (IV) fentanyl.

NCT ID: NCT03744663 Withdrawn - Opioid Use Clinical Trials

Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

Start date: June 2022
Phase: Phase 2
Study type: Interventional

While substance use disorders have been found to have relapse rates on part with other chronic illnesses such as hypertension and asthma long term abstinence remains elusive for many. The FDA has recently approve a long acting subcutaneous injectable formulation of buprenorphine. This study aims to determine the feasibility of enrolling and randomizing patients seeking treatment at an outpatient substance abuse clinic to buprenorphine/naloxone films which dissolve under the tongue vs. long acting buprenorphine injection with all other treatment aspects held constant. The study also aims to determine the effectiveness of monthly injections of Sublocade® compared to daily oral Suboxone® SL therapy in the treatment of moderate to severe opioid use disorder after twenty-four weeks of treatment.

NCT ID: NCT03744065 Completed - Pain, Postoperative Clinical Trials

Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement

Start date: November 19, 2018
Phase: N/A
Study type: Interventional

The nerves from lumbar plexus (LP) are the current target to achieve analgesia after a total hip arthroplasty (THA). Lumbar plexus block (LPB) is an alternative that provides optimal postoperative analgesia. However, many adverse effects and complications have been reported due to its proximity to vital structures. Because of these shortcomings, an alternative to block the LP nerves is required. In a recent trial suprainguinal Fascia Iliaca Block (SFIB) was reported to provide reliable analgesia in THA. SFIB may carry a lower risk profile, however, no study has compared the efficacy of LPB and SFIB in this setting. Thus, this randomized trial is set out to compare US guided LPB and SFIB for analgesia after THA. The hypothesis is that both blocks would result in similar postoperative opioid (morphine) consumption at 24 hours and, therefore, designed the study as an equivalence trial.

NCT ID: NCT03743493 Completed - Opioid Use Clinical Trials

PCORnet Opioid Surveillance Study

Start date: July 1, 2018
Phase:
Study type: Observational

The overarching objective of this project is to demonstrate and assess the feasibility of using the Patient Centered Outcomes Research Network (PCORnet) Common Data Model for opioid surveillance to complement existing and support future initiatives. This project will characterize risk factors, processes, and outcomes related to opioid use, misuse, and abuse. It will quantify the utility of data stored in the PCORnet Common Data Model format stewarded by healthcare organizations participating in PCORnet.

NCT ID: NCT03732469 Terminated - Opioid Use Clinical Trials

Rectal Acetaminophen Use During Oocyte Retrievals to Reduce Post-Operative Opioid Utilization

Start date: November 1, 2019
Phase: Phase 4
Study type: Interventional

The primary aim of this study is to evaluate the administration of rectal acetaminophen to current and standard anesthesia and analgesia protocol in oocyte retrievals would reduce postoperative utilization of opioids (Tylenol with codeine) in fertility patients.

NCT ID: NCT03730402 Terminated - Opioid Use Clinical Trials

Laparoscopic Assisted Plane Block (LAPB) Trial

Start date: February 4, 2019
Phase: Phase 4
Study type: Interventional

This study attempts to demonstrate improvement in analgesia in a more diverse laparoscopic surgery group with the use of laparoscopic assisted transversus abdominis plane blocks. The investigators will compare bupivacaine (treatment arm 1) versus liposomal bupivacaine (treatment arm 2) versus port site injection of local anesthesia with injection of saline placebo (control). The hypothesis is that liposomal bupivacaine will result in improved analgesia when compared to bupivacaine LAPB and control. The investigators further hypothesize that bupivacaine LAPB will be more effective than the control.

NCT ID: NCT03726476 Completed - Pain, Postoperative Clinical Trials

Expectations and Pain Control Advancement In surgeRy: The REPAIR Trial

REPAIR
Start date: September 10, 2019
Phase: N/A
Study type: Interventional

This is a randomized control trial that aims to evaluate whether patient-centered education, compared to routine education, decreases narcotic consumption without interfering with return to physical activity following hospital discharge. In addition, it will test whether patient-centered education decreases the quantity of narcotics prescribed and/or increases patient satisfaction and preparedness.